Endpoint definition
↥| Name | DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT |
|---|---|
| Long name | Drug-induced systemic lupus erythematosus |
| Hospital Discharge registry | ICD-10: M320 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| Name | DRUGADVERS_SYSTEMIC_LUPUS_ERYTHEMAT |
|---|---|
| Long name | Drug-induced systemic lupus erythematosus |
| Hospital Discharge registry | ICD-10: M320 |
| Level in the ICD-hierarchy | C |
| First defined in version | DF5 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 101 | 87 | 14 |
| Unadjusted prevalence (%) | 0.05 | 0.07 | 0.01 |
| Mean age at first event (years) | 45.96 | 45.43 | 49.29 |
| Case fatality at 5-years (%) | 2.97 | 3.45 | 0.00 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 2.0 |
| Recurrence at 6 months (%) | 37.62 | 36.78 | 42.86 |
before Drug-induced systemic lupus erythematosus
after Drug-induced systemic lupus erythematosus
Loading survival analyses plot…
Loading survival analyses table…